Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
About this item
Full title
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Publisher
London: Normans Media Ltd
Journal title
M2 EquityBites, 2015
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2 EQUITYBITES-March 17, 2015-Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera (C)1994-2015 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Incyte (Nasdaq: INCY) revealed on Monday that it has received European Commission's approval for Jakavi (ruxolitin...
Alternative Titles
Full title
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1663800160
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1663800160
How to access this item
Log in as a Library member
